Ironwood Pharmaceuticals Q4 FY2022 Investor Update

Loading viewer...

earnings

Format: PDF earnings

Ironwood Pharmaceuticals Q4 and full-year 2022 investor update presented February 16, 2023, covering financial results, LINZESS commercial performance, and pipeline progress including linaclotide pediatric indications, CNP-104 for PBC, and IW-3300 development programs.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Ironwood Pharmaceuticals

View all →

FloQast_Ironwood%20Pharmaceuticals%20Case%20Study_2021

brochure

presentation

Similar earningss from other companies

Browse all →

Bank of Georgia Group 2Q22 1H22 Performance Results Presentation

earnings

63 Pages

Bank of Georgia Group

Lloyd's of London Full Year Results 2021

earnings